S, B., S, G., SS, R., N, B., & D, S. (2021). A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus. Dove Medical Press.
Cita Chicago Style (17a ed.)S, Brar, Ganesh S, Reddy SS, BN N, y Shahanand D. A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus. Dove Medical Press, 2021.
Cita MLA (8a ed.)S, Brar, et al. A Prospective, Comparative, Clinical Study to Evaluate the Safety and Efficacy of Two Different 0.1% Riboflavin Solutions Used in Collagen Crosslinking Treatment for Patients with Keratoconus. Dove Medical Press, 2021.